Association of Chronic Liver Disease and Mortality in Patients With Aneurysmal Subarachnoid Hemorrhage

Yu Zhang1, Linjie Li1, Lu Jia1

  • 1Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China (Y.Z., L.L., L.J., C.Y., Y.C., F.F.).

Stroke
|July 20, 2021
PubMed

Insights

Chronic liver disease (CLD) significantly increases mortality in patients with aneurysmal subarachnoid hemorrhage (aSAH). A high Model for End-Stage Liver Disease score further elevates mortality risk in these patients.

Area of Science:

  • Neurology
  • Hepatology
  • Critical Care Medicine

Background:

  • Chronic liver disease (CLD) is a known risk factor for poor outcomes in critically ill patients.
  • The impact of CLD on mortality in aneurysmal subarachnoid hemorrhage (aSAH) patients is not well understood.

Purpose of the Study:

  • To investigate the association between CLD and in-hospital mortality in patients with aSAH.
  • To determine if liver disease severity, using the Model for End-Stage Liver Disease (MELD) score, influences mortality in aSAH patients with CLD.

Main Methods:

  • Retrospective cohort study of 6228 aSAH patients admitted between 2009 and 2019.
  • Propensity score matching was used to compare mortality between aSAH patients with and without CLD.
  • Analysis of the association between MELD score and mortality within the CLD subgroup.

Main Results:

  • A total of 489 (7.9%) aSAH patients had CLD.
  • CLD was significantly associated with increased in-hospital mortality in aSAH patients (OR, 2.04; 95% CI, 1.43–2.92).
  • In aSAH patients with CLD, a higher MELD score correlated with increased mortality risk.

Conclusions:

  • CLD is an independent risk factor for increased mortality in aSAH patients.
  • Liver disease severity, indicated by MELD score, is crucial for predicting outcomes in aSAH patients with CLD.
Abstract

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
55
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
60
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
193